75 results
Page 2 of 4
8-K
EX-1.1
0zwvy0x3mrnmvyi
22 Aug 22
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
4:13pm
8-K
EX-4.1
rdqpuj1t4m4e2ql6cu9d
22 Aug 22
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
4:13pm
424B5
coosd
19 Aug 22
Prospectus supplement for primary offering
8:42am
424B5
ntkf4qj
19 Aug 22
Prospectus supplement for primary offering
8:37am
424B5
ykk87li0
16 Aug 22
Prospectus supplement for primary offering
5:26pm
8-K
EX-99.1
qrljjh
12 Aug 22
UNITY Biotechnology Announces Positive Data in Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:18am
8-K
EX-99.2
qun kjmz7dcci1tsg1
12 Aug 22
UNITY Biotechnology Announces Positive Data in Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:18am
424B5
ox5iq927m5h8cr3zt
13 May 22
Prospectus supplement for primary offering
4:18pm
PRE 14A
qhl cqq9jc
12 Apr 22
Preliminary proxy
4:02pm
8-K
EX-10.1
ccr0as0
29 Sep 21
Entry into a Material Definitive Agreement
5:26pm
424B5
7uzsuu yiw
29 Sep 21
Prospectus supplement for primary offering
5:24pm
8-K
EX-99.1
l36weeb83g2h130zpxug
10 Aug 21
UNITY Biotechnology, Inc. Reports Second Quarter 2021 Financial Results and Business Updates
4:05pm
8-K/A
EX-99.2
2rutr6hsonhfsv xi
7 Jul 21
Financial Statements and Exhibits
8:00am